Crossmark

Alzheimer's Disease Linkage to Real-World Evidence (AD-LINE) Study: Linking Claims Data to Phase 3 GRADUATE Study of Gantenerumab

Crossref DOI link: https://doi.org/10.14283/jpad.2024.115

Published Print: 2024-10

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Fillit, H.

Seleri Assunção, S.

Majda, Thomas

Ng, C.D.

To, T.M.

Abbass, I.M.

Raimundo, K.

Wallick, C.

Tcheremissine, O.V.
License Information

Text and Data Mining valid from 2024-10-01

Text and Data Mining valid from 2024-10-01

Version of Record valid from 2025-01-06
More Information

This article is maintained by: Elsevier

Article Title: Alzheimer's Disease Linkage to Real-World Evidence (AD-LINE) Study: Linking Claims Data to Phase 3 GRADUATE Study of Gantenerumab

Journal Title: The Journal of Prevention of Alzheimer's Disease

CrossRef DOI link to publisher maintained version: https://doi.org/10.14283/jpad.2024.115

Content Type: article

Copyright: Copyright © 2024 THE AUTHORS. Published by Elsevier Masson SAS on behalf of SERDI Publisher. Published by Elsevier Masson SAS